Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Young adults with Ewing's sarcoma].

J M Kerst1, F Van Coevorden, J Peterse

  • 1Antoni van Leeuwenhoek Ziekenhuis, afd. Medisch-Oncologische Disciplines, Plesmanlaan 121, 1066 CX Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|July 31, 2004
PubMed
Summary

Ewing's sarcoma, a rare bone cancer, can affect young adults. Treatment for localized disease may involve chemotherapy, surgery, and radiotherapy, with varied outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.

Breast cancer research : BCR·2026
Same author

Pathological complete response and survival after neoadjuvant chemotherapy in patients with stage I TNBC: a registry-based study.

ESMO open·2025
Same author

Balancing the dose: A meta-analysis of preoperative radiotherapy strategies for soft tissue sarcomas.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma.

ESMO open·2025
Same author

Case-only analysis in small studies of predictive biomarkers.

Scientific reports·2025

Area of Science:

  • Oncology
  • Genetics
  • Musculoskeletal Diseases

Background:

  • Ewing's sarcoma is a rare musculoskeletal malignancy primarily affecting children and adolescents, but also occurring in young adults.
  • It typically presents as a painful swelling of bone or soft tissue, sometimes accompanied by systemic symptoms like weight loss and fever.
  • Metastases at diagnosis, particularly to the lungs, bone, and bone marrow, occur in 20-25% of cases.

Observation:

  • Three male patients (22, 30, 30 years old) were diagnosed with Ewing's sarcoma via biopsy and t(11;22)-translocation.
  • The youngest patient initially withheld radiotherapy due to good chemotherapy/surgery response but experienced recurrence, necessitating further intensive treatment including stem cell transplant for remission.
  • One 30-year-old patient with localized disease achieved good condition after chemotherapy, surgery, and radiotherapy, while the other with extensive metastases died within 8 months.

Findings:

  • Treatment strategies for Ewing's sarcoma, including chemotherapy, surgery, and radiotherapy, yield variable outcomes depending on disease extent and patient response.
  • Recurrence can occur even after initial successful treatment, requiring escalated therapeutic interventions.
  • The t(11;22)-translocation is a key diagnostic marker for Ewing's sarcoma.

Implications:

  • Optimal management of Ewing's sarcoma necessitates a multidisciplinary approach within a study setting.
  • Early diagnosis and tailored treatment intensification are crucial for improving outcomes in young adults with this rare cancer.
  • Further research into novel therapeutic strategies is warranted for patients with metastatic or recurrent Ewing's sarcoma.

Related Experiment Videos